human albumin

Human Albumin is a specialized pharmaceutical manufacturing company based in Gödöllő, Hungary, that focuses on the production of plasma-derived medicinal products. The company was established as a standalone entity following the acquisition of the plasma business of Human BioPlazma by the Italian biopharmaceutical group Kedrion in 2007. It operates a sophisticated plasma fractionation facility that produces essential therapies including human albumin, intravenous immunoglobulins, and coagulation factors. As a key subsidiary of Kedrion, the company plays a vital role in the global supply chain for treatments targeting rare and serious diseases such as hemophilia and immune deficiencies. Its operations are fully compliant with international Good Manufacturing Practice (GMP) standards, serving both European and global markets.